
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12343884
[patent_doc_number] => 09950125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Needle assisted jet injection administration of testosterone compositions
[patent_app_type] => utility
[patent_app_number] => 13/857859
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 22357
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857859
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857859 | Needle assisted jet injection administration of testosterone compositions | Apr 4, 2013 | Issued |
Array
(
[id] => 8976037
[patent_doc_number] => 20130209467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'METHOD OF TREATING FIBROPROLIFERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/856035
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17278
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13856035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/856035 | Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis | Apr 2, 2013 | Issued |
Array
(
[id] => 10209273
[patent_doc_number] => 20150094263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'Use of Neuregulin to Treat Peripheral Nerve Injury'
[patent_app_type] => utility
[patent_app_number] => 14/389655
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19778
[patent_no_of_claims] => 245
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389655 | Use of Neuregulin to Treat Peripheral Nerve Injury | Mar 28, 2013 | Abandoned |
Array
(
[id] => 11872407
[patent_doc_number] => 09744155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk'
[patent_app_type] => utility
[patent_app_number] => 13/829773
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 37
[patent_no_of_words] => 20830
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829773 | IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk | Mar 13, 2013 | Issued |
Array
(
[id] => 10256348
[patent_doc_number] => 20150141345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'NOVEL COMPOUNDS AND METHODS FOR INHIBITING CELL DEATH'
[patent_app_type] => utility
[patent_app_number] => 14/401504
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24186
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401504
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401504 | Compounds and methods for inhibiting cell death | Mar 11, 2013 | Issued |
Array
(
[id] => 12283213
[patent_doc_number] => 09931385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Methods of inhibiting gonad maturation
[patent_app_type] => utility
[patent_app_number] => 14/383564
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13837
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383564
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/383564 | Methods of inhibiting gonad maturation | Mar 10, 2013 | Issued |
Array
(
[id] => 9295274
[patent_doc_number] => 20140038908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and Turnover'
[patent_app_type] => utility
[patent_app_number] => 13/780181
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 41927
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13780181
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/780181 | Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and Turnover | Feb 27, 2013 | Abandoned |
Array
(
[id] => 9269671
[patent_doc_number] => 20140024589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Follicle Stimulating Hormone Superagonists'
[patent_app_type] => utility
[patent_app_number] => 13/770606
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 16612
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13770606
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/770606 | Follicle Stimulating Hormone Superagonists | Feb 18, 2013 | Abandoned |
Array
(
[id] => 9793292
[patent_doc_number] => 20150005236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'USE OF BETA-NERVE GROWTH FACTOR FOR INDUCING OVULATION IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 14/376406
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7051
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376406
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376406 | USE OF BETA-NERVE GROWTH FACTOR FOR INDUCING OVULATION IN MAMMALS | Feb 7, 2013 | Abandoned |
Array
(
[id] => 10421170
[patent_doc_number] => 20150306181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'DELIVERY OF BIOTHERAPEUTICS TO THE BRAIN'
[patent_app_type] => utility
[patent_app_number] => 14/376969
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 21172
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376969
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376969 | DELIVERY OF BIOTHERAPEUTICS TO THE BRAIN | Feb 5, 2013 | Abandoned |
Array
(
[id] => 8950082
[patent_doc_number] => 20130195862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATION'
[patent_app_type] => utility
[patent_app_number] => 13/754234
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 23042
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754234
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/754234 | Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor | Jan 29, 2013 | Issued |
Array
(
[id] => 10954548
[patent_doc_number] => 20140357571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS'
[patent_app_type] => utility
[patent_app_number] => 14/371139
[patent_app_country] => US
[patent_app_date] => 2013-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9725
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371139
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/371139 | GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS | Jan 8, 2013 | Abandoned |
Array
(
[id] => 10450588
[patent_doc_number] => 20150335602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'IMPROVEMENT OF COGNITIVE FUNCTION IN PRETERM INFANTS THAT ARE SMALL FOR GESTATIONAL AGE'
[patent_app_type] => utility
[patent_app_number] => 14/759897
[patent_app_country] => US
[patent_app_date] => 2013-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7983
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759897 | IMPROVEMENT OF COGNITIVE FUNCTION IN PRETERM INFANTS THAT ARE SMALL FOR GESTATIONAL AGE | Jan 8, 2013 | Abandoned |
Array
(
[id] => 8853141
[patent_doc_number] => 20130142816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY'
[patent_app_type] => utility
[patent_app_number] => 13/729923
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10731
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729923
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/729923 | Administration of transfer factor for improving reproductive health | Dec 27, 2012 | Issued |
Array
(
[id] => 10382180
[patent_doc_number] => 20150267187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/728499
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13171
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13728499
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/728499 | Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic Proteins | Dec 26, 2012 | Abandoned |
Array
(
[id] => 9805177
[patent_doc_number] => 20150017122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA'
[patent_app_type] => utility
[patent_app_number] => 14/367604
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4670
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367604
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367604 | CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA | Dec 20, 2012 | Abandoned |
Array
(
[id] => 8964120
[patent_doc_number] => 20130203722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASE AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/722672
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20834
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722672 | ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASE AND DISORDERS | Dec 19, 2012 | Abandoned |
Array
(
[id] => 10391712
[patent_doc_number] => 20150276719
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2015-10-01
[patent_title] => 'A RAPID QUANTITATIVE ASSAY TO MEASURE CFTR FUNCTION IN A PRIMARY INTESTINAL CULTURE MODEL'
[patent_app_type] => utility
[patent_app_number] => 14/367061
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 26388
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367061 | Rapid quantitative assay to measure CFTR function in a primary intestinal culture model | Dec 18, 2012 | Issued |
Array
(
[id] => 10391712
[patent_doc_number] => 20150276719
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2015-10-01
[patent_title] => 'A RAPID QUANTITATIVE ASSAY TO MEASURE CFTR FUNCTION IN A PRIMARY INTESTINAL CULTURE MODEL'
[patent_app_type] => utility
[patent_app_number] => 14/367061
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 26388
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367061 | Rapid quantitative assay to measure CFTR function in a primary intestinal culture model | Dec 18, 2012 | Issued |
Array
(
[id] => 11643322
[patent_doc_number] => 09664688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Method of identifying risk for thyroid disorder'
[patent_app_type] => utility
[patent_app_number] => 13/705944
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6733
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/705944 | Method of identifying risk for thyroid disorder | Dec 4, 2012 | Issued |